Fiber supplementation reduced visceral and non-visceral fat, fasting glucose, HbA1c, fasting insulin, and uric acid in the fiber group. No significant between-group differences were observed after adjusting for weight loss. A trend for liver fat reduction in individuals with NAFLD was noted in the fiber group. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.